Evidence map›Paper›PMID 32547853›Full record

ArticlePeerJ2020

A new aggressive xenograft model of human colon cancer using cancer-associated fibroblasts.

Ester Fernando-Macías, Maria Teresa Fernández-García, Eva García-Pérez, Belén Porrero Guerrero, Camilo López-Arévalo, Raquel Rodríguez-Uría, Sandra Sanz-Navarro, José Fernando Vázquez-Villa, María Carmen Muñíz-Salgueiro, Laura Suárez-Fernández and 5 more

Open access · goldAbstract read
In one paragraph

Article in PeerJ, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Unraveling the role of cancer-associated fibroblasts in colorectal cancer.World journal of gastrointestinal oncology · 2024
    Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Ester Fernando-MacíasService of Surgery, Hospital Universitario Central de Asturias, Oviedo, Spain.
Maria Teresa Fernández-GarcíaLaboratory of Department of Molecular Histopathology in Animal Cancer Models, Oncology University Institute of the Principality of Asturias, University of Oviedo, Oviedo, Spain.
Eva García-PérezOphtalmologic Research Foundation, Oviedo, Spain.
Belén Porrero GuerreroService of Surgery, Hospital Universitario Central de Asturias, Oviedo, Spain.
Camilo López-ArévaloService of Surgery, Hospital Universitario Central de Asturias, Oviedo, Spain.
Raquel Rodríguez-UríaService of Surgery, Hospital Universitario Central de Asturias, Oviedo, Spain.
Sandra Sanz-NavarroService of Surgery, Hospital Universitario Central de Asturias, Oviedo, Spain.
José Fernando Vázquez-VillaInstituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain.
María Carmen Muñíz-SalgueiroLaboratory of Department of Molecular Histopathology in Animal Cancer Models, Oncology University Institute of the Principality of Asturias, University of Oviedo, Oviedo, Spain.
Laura Suárez-FernándezInstituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain.
José A GalvánTranslational Research Unit, Institute of Pathology, University of Bern, Bern, Switzerland.ORCID 0000-0003-3138-7642
Clara Barneo-CaragolInstituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain.
Marcos García-OcañaBiotechnological and Biomedical Assays Unit, Technical-Scientific Services, University of Oviedo, Oviedo, Spain.
Juan R de Los ToyosInstituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain.
Luis Barneo-SerraService of Surgery, Hospital Universitario Central de Asturias, Oviedo, Spain.ORCID 0000-0001-9410-4262
Hospital Universitario Central de Asturias · ESUniversidad de Oviedo · ESInstituto de Investigación Sanitaria del Principado de Asturias · ESUniversity of Bern · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundColorectal cancer is the second leading cause of cancer death. Almost half of the patients present recurrence within 5 years after the treatment of the primary tumor, the majority, with metastasis. On the other hand, in the search for new animal models that simulate metastatic cancer, it has been suggested that fibroblasts immersed in the peritumoral stroma (cancer-associated fibroblasts (CAFs)), play a relevant role in the development of cancer. The objective of this study was to identify an adequate animal model to study metastatic colon cancer and the application of new treatments.

methodsHuman CAFs and normal fibroblasts (NF) for transplant and culture were obtained from surgical fresh samples of patients with adenocarcinoma of sigmoid colon. Stromal cell purity was evaluated by morphology and immunostaining with vimentin (VIM) as a fibroblast marker and anti-proColXIα1 as a specific human CAF marker. Phenotypic characterization of cultured stromal cells was performed by co-staining with mesenchymal and epithelial cell markers. For identification in mice, human CAFs were labeled with the PKH26 red fluorescence dye. Cell line HT-29 was used as tumor cells. Transplant in the head of the pancreas of 34 SCID mice was performed in four different groups, as follows: I. 150,000 CAFS (

resultsThe CAFs and NF cultured were proColXIα1+/VIM+, proColXIα1/alphaSMA+ and proColXIα1+/CK19+ in different proportions without differences among them, but the CAFs growth curve was significantly larger than that of the NF (

conclusionOur experiments demonstrate that cultured CAFs have a higher growth than NF and that when human CAFs are associated to human tumor cells, larger tumors with liver and lung metastases are generated than if only colon cancer cells with/without NF are transplanted. This emphasizes the importance of the tumor stroma, and especially the CAFs, in the development of cancer.

Indexed as

Animal modelCAFsFibroblasts cultureProColXIα1Xenograft

Identifiers

PMID32547853
PMCPMC7275677
OpenAlexW3033433122

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.